Tuesday, June 11, 2019
Not Much Fizz in LaCroix Right Now

Wednesday, May 29, 2019
An Example of Calcbench, Excel, and Insight

Monday, May 20, 2019
Research Paper: Capex Spending

Thursday, May 16, 2019
Psst: Got Any Weed?

Wednesday, May 15, 2019
Open Letter: SEC Proposed Rule for BDCs

Friday, May 10, 2019
General Motors and Workhorse

Monday, May 6, 2019
How to Find Earnings Release Data

Tuesday, April 23, 2019
Following Restructuring Costs Over Time

Monday, April 22, 2019
Capex Spending: More Than You Might Think

Saturday, April 13, 2019
When AWS Takes Over the World

Thursday, April 11, 2019
Data Trends in Focus: Restructuring Costs

Sunday, April 7, 2019
How One Customer Crushed It With Calcbench

Thursday, April 4, 2019
TJX Shows Complexity of Leasing Costs Reporting

Tuesday, April 2, 2019
CEO Pay Ratios: Some 2018 Thoughts

Wednesday, March 27, 2019
Corporate Spending: Where It Goes, 2017 vs. 2018

Monday, March 25, 2019
Health Insurers: A Bit Winded?

Friday, March 22, 2019
Our New Master Class Video

Thursday, March 21, 2019
Tech Data’s Goodwill Adjustment

Tuesday, March 19, 2019
There’s Taxes, and There’s Taxes

Saturday, March 16, 2019
Adventures in Tax Cuts and Net Income

Archive  |  Search:
Et Tu Puerto Rico?
Monday, June 29, 2015

Yes, this is a troubling sign. Do you want to get a feel for corporate exposure to Puerto Rico? We did a quick lookup within Calcbench to see if any firm disclosed Puerto Rican sales and moreover, Puerto Rico in general.

Below is a list of firms that explitly list exposure to Puerto Rico and their 2014 revenues that are tied to the island. There is a caveat that some firm lump Puerto Rican revenues with US revenues, so we want to caution that you may need to look a little further than this analysis. But you can do that with a little time and a Calcbench subscription!

Firm Revenue
Aes Corp $348,000,000
Clean Harbors Inc $2,414,600,000
EVERTEC, Inc. $312,569,000
Greatbatch, Inc. $127,702,000
Popular Inc $1,024,416,000
Rcm Technologies Inc $6,251,000
TerraForm Power, Inc. $86,210,000
Valeant Pharmaceuticals International, Inc. $4,473,000,000
W R Grace & Co $78,700,000

FREE Calcbench Premium
Two Week Trial

Research Financial & Accounting Data Like Never Before. More features and try our Excel add-in. Sign up now to try the Premium Suite.